References
- Taasan VC, Block AJ, Boysen PG, Wynne JW. Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 1981; 71: 240–5.
- Robinson RW, White DP, Zwillich CW. Moderate alcohol ingestion increases upper airway resistance in normal subjects. Am Rev Respir Dis 1985; 132: 1238–41.
- Scrima L, Broudy M, Nay KN, Cohn MA. Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential and proposed mechanism of action. Sleep 1982; 5: 318–28.
- Remmers JE. Obstructive sleep apnea. A common disorder exacerbated by alcohol. Am Rev Respir Dis 1984; 130: 153–5.
- Eccles R, Tolley NS. The effect of alcohol ingestion upon nasal airway resistance. Rhinology 1987; 25: 245–8.
- Krol RC, Knuth SL, Barlett D Jr. Selective reduction of genioglossal muscle activity by alcohol in human sub-jects. Am Rev Respir Dis 1984; 129: 247–50.
- Tan ET, Lambie DG, Johnson RH, Robinson BJ, Whiteside EA. Sleep apnoea in alcoholic patients after withdrawal. Clin Sci 1985; 69: 655–61.
- Vitiello MV, Prinz PN, Personius JP, Nuccio MA, Koerker RM, Scurfield R. Nighttime hypoxemia is increased in abstaining chronic alcoholic men. Alcohol Clin Exp Res 1990; 14: 38–41.
- Jalleh R, Fitzpatrick MF, Mathur R, Douglas NJ. Do patients with sleep apnea/hypopnea syndrome drink more alcohol? Sleep 1992; 15: 319–21.
- Rains V, Ditzler T, Newsome R, Lee-Gushi S, Morgan E. Alcohol and sleep apnea. Hawaii Med J 1991; 50: 282–7.
- Hermansson U, Helander A, Huss A, Brandt L, Rönnberg S. The alcohol use disorders identification test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res 2000; 24: 180–7.
- Andréasson S, Graffman K. Alcohol prevention in primary care. Patients receptive to questions concerning alcohol and life. Läkartidningen 2002; 99: 4252–5.
- Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37: 2029–37.
- Allen JP, Litten RZ, Anton RF, Cross GM. Carbohy-drate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 1994; 18: 799–812.
- Beck 0, Borg S, Eriksson L, Lundman A. 5-Hydroxy-tryptophol in the cerebrospinal fluid and urine of alcoholics and healthy subjects. Naunyn Schmiedebergs Arch Pharmacol 1982; 321: 293–7.
- Sillanaukee P. Laboratory markers of alcohol abuse. Alcohol Alcohol 1996; 31: 613–6.
- Beck O, Helander A, Carlsson S, Borg S. Changes in serotonin metabolism during treatment with the alde-hyde dehydrogenase inhibitors disulfiram and cyana-mide. Pharmacol Toxicol 1995; 77: 323–6.
- Helander A, Beck O, Jones AW. Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol and 5-hydroxytryptophol. Clin Chem 1996; 42: 618–24.
- Beck 0, Lin Z, Brodin K, Borg S, Hjemdahl P. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS. J Anal Toxicol 1997; 21: 554–7.
- Hermansson U, Helander A, Brandt L, Huss A, Rönnberg S. The alcohol use disorders identification test and carbohydrate-deficient transferrin in alcohol-related sickness absence. Alcohol Clin Exp Res 2002; 26: 28–35.
- Mutzell S, Tibbelin G, Bergman H. Heavy alcohol drinking and related symptoms in a population study of urban men. Alcohol Alcohol 1987; 22: 419–26.